{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:02:13Z","timestamp":1762326133950,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacig.2025.100557","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T08:21:08Z","timestamp":1755246068000},"page":"100557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world treatment patterns in patients with chronic rhinosinusitis with nasal polyps who initiated dupilumab: A US claims analysis"],"prefix":"10.1016","volume":"4","author":[{"given":"Jayant M.","family":"Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Fillbrunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakash","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100557_bib1","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.jaip.2023.04.054","article-title":"The management of chronic rhinosinusitis with nasal polyps (CRSwNP) with biologics","volume":"11","author":"Wautlet","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100557_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2500\/aap.2019.40.4182","article-title":"A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis","volume":"40","author":"Palmer","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jacig.2025.100557_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X221128930","article-title":"Elucidating the real-world burden of chronic rhinosinusitis with nasal polyps in patients in the USA","volume":"6","author":"Benson","year":"2022","journal-title":"OTO Open"},{"key":"10.1016\/j.jacig.2025.100557_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1398-9995.2008.01828.x","article-title":"Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life","volume":"63","author":"Alobid","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100557_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0003489415576181","article-title":"Altered quality of life and psychological health (SCL-90-R) in patients with chronic rhinosinusitis with nasal polyps","volume":"124","author":"Chung","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"suppl S29","key":"10.1016\/j.jacig.2025.100557_bib6","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jacig.2025.100557_bib7","first-page":"544","article-title":"Endotypes of chronic rhinosinusitis with nasal polyps with and without NSAID aeuro\" intolerance","volume":"58","author":"Steiner","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jacig.2025.100557_bib8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100557_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2500\/ajra.2014.28.4076","article-title":"A comparative and descriptive study of asthma in chronic rhinosinusitis with nasal polyps","volume":"28","author":"Hakansson","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jacig.2025.100557_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100557_bib11","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2025.100557_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2019.102286","article-title":"Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps","volume":"41","author":"Rosati","year":"2020","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jacig.2025.100557_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","article-title":"Commonality of the IL-4\/IL-13 pathway in atopic diseases","volume":"13","author":"Gandhi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100557_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/all.13685","article-title":"Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis","volume":"74","author":"Jonstam","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100557_bib16","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/jcm11102684","article-title":"Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a \"real-life\" observational study in the first year of treatment","volume":"11","author":"De","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacig.2025.100557_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12948-022-00171-2","article-title":"Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life","volume":"20","author":"Nettis","year":"2022","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jacig.2025.100557_bib18","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/all.15772","article-title":"Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase IV real-life study (DUPIREAL)","volume":"78","author":"De","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100557_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jacig.2025.100557_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13223-023-00855-7","article-title":"Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world study","volume":"19","author":"Silver","year":"2023","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100557_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1159\/000514262","article-title":"Real-life experience of monoclonal antibody treatments in chronic rhinosinusitis with nasal polyposis","volume":"182","author":"Meier","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jacig.2025.100557_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.anai.2023.11.008","article-title":"Persistent use of dupilumab in adults with asthma or chronic rhinosinusitis with nasal polyps","volume":"132","author":"Corey","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2025.100557_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4193\/RHINOL\/24.003","article-title":"Trends in dupilumab persistence among patients with chronic rhinosinusitis with nasal polyps","volume":"7","author":"Stack","year":"2024","journal-title":"Rhinol Online"},{"key":"10.1016\/j.jacig.2025.100557_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jacig.2025.100557_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JAA.S420140","article-title":"Dupilumab reduces asthma disease burden and recurrent scs use in patients with CRSwNP and coexisting asthma","volume":"17","author":"Gurnell","year":"2024","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jacig.2025.100557_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jaci.2022.10.026","article-title":"The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis","volume":"151","author":"Rank","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100557_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40463-021-00493-2","article-title":"Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis","volume":"50","author":"Thamboo","year":"2021","journal-title":"J Otolaryngol Head Neck Surg"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325001584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325001584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:11:55Z","timestamp":1762323115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325001584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772829325001584"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100557","relation":{},"ISSN":["2772-8293"],"issn-type":[{"type":"print","value":"2772-8293"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world treatment patterns in patients with chronic rhinosinusitis with nasal polyps who initiated dupilumab: A US claims analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Regeneron Pharmaceuticals and Sanofi. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100557"}}